Journal
JOURNAL OF NERVOUS AND MENTAL DISEASE
Volume 203, Issue 5, Pages 310-318Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/NMD.0000000000000284
Keywords
Early intervention; psychosis; prevention; service reform
Categories
Funding
- Colonial Foundation
- National Health and Medical Research Council of Australia
- NARSAD
- Stanley Foundation
- Australian government
- Victorian government
- Janssen-Cilag
- Astra Zeneca
- Bristol-Meyer-Squibb
- Eli Lilly
- Pfizer
Ask authors/readers for more resources
Early intervention for potentially serious disorder is a fundamental feature of healthcare across the spectrum of physical illness. It has been a major factor in the reductions in morbidity and mortality that have been achieved in some of the non-communicable diseases, notably cancer and cardiovascular disease. Over the past two decades, an international collaborative effort has been mounted to build the evidence and the capacity for early intervention in the psychotic disorders, notably schizophrenia, where for so long deep pessimism had reigned. The origins and rapid development of early intervention in psychosis are described from a personal and Australian perspective. This uniquely evidence-informed, evidence-building and cost-effective reform provides a blueprint and launch pad to radically change the wider landscape of mental health care and dissolve many of the barriers that have constrained progress for so long.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available